Price Data Unavailable
Lixte Biotechnology Holdings, Inc. is a biotech company that identifies enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. Lixte's product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or X-ray and immune checkpoint blockers.
WallstreetBets Trending Stocks (24h)